U.S. FDA grants orphan drug designation to Adcentrx Therapeutics’ ADRX-0405 STEAP1 ADC for gastric cancer

Henlius receives global regulatory approvals for Phase 2 MRCT of its PD-L1 ADC HLX43 on...

PDS Biotech announces colorectal cancer cohort of Phase 2 clinical trial with PDS01 ADC met...

Avenzo Therapeutics announces first patient dosed in Phase 1/2 clinical study of AVZO-1418, a potential...

Adagene and ConjugateBio partner to develop novel antibody drug conjugate

Lotte Biologics, Abtis collaborate on next-generation ADC technology development